Turbogen(TRBG)
$3.49+0.08 (+2.35%)
TRBG
Turbogen financials statements
$3.49
At close:+0.08 (+2.35%)
Turbogen (TRBG) Ratios
5 Followers
Turbogen Ratios
TRBG's free cash flow for Q2 2026 was ₪-8.13K. For the 2026 fiscal year, TRBG's free cash flow was decreased by ₪-166.00 and operating cash flow was ₪-8.12M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.65 | 0.07 | 0.12 | 0.62 | 2.66 |
| Quick Ratio | 0.65 | 0.07 | 0.12 | 0.62 | 2.66 |
| Cash Ratio | 0.00 | 0.06 | 0.09 | 578.90 | 2.46 |
| Solvency Ratio | -2.38 | -0.65 | -0.75 | -1.11 | -2.05 |
| Operating Cash Flow Ratio | -0.53 | -0.31 | -0.72 | -1.29 | -1.73 |
| Short-Term Operating Cash Flow Coverage | -0.61 | -2.75 | -8.20 | -16.59 | -11.76 |
| Net Current Asset Value | ₪ -10.94M | ₪ -30.82K | ₪ -22.37K | ₪ -9.75K | ₪ 8.04K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.18 | 0.77 | 0.52 | 0.17 | 0.08 |
| Debt-to-Equity Ratio | -1.46 | -0.13 | -0.11 | -0.28 | 0.15 |
| Debt-to-Capital Ratio | 3.17 | -0.15 | -0.12 | -0.38 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
| Financial Leverage Ratio | -1.24 | -0.17 | -0.21 | -1.66 | 1.90 |
| Debt Service Coverage Ratio | -0.56 | -4.67 | -10.17 | -0.01 | -0.01 |
| Interest Coverage Ratio | -1.00 | 0.00 | 0.00 | -8.16 | -10.73 |
| Debt to Market Cap | 0.07 | 0.02 | 0.03 | 0.01 | 0.00 |
| Interest Debt Per Share | 3.40 | 0.26 | 0.16 | 167.45 | 167.48 |
| Net Debt to EBITDA | -0.77 | -0.21 | -0.03 | 389.42 | 0.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 0.10% | 0.10% |
| EBT Per EBIT | 212.11% | 181.64% | 107.95% | 101.98% | 105.30% |
| Return on Assets (ROA) | -329.09% | -445.62% | -439.99% | -181.00% | -98.28% |
| Return on Equity (ROE) | 407.97% | 76.66% | 92.82% | 300.00% | -186.88% |
| Return on Capital Employed (ROCE) | 429.76% | 67.14% | 118.00% | 1644881.89% | -137262.75% |
| Return on Invested Capital (ROIC) | -191.42% | 81.03% | 135.01% | -4244018.06% | -125444.68% |
| Return on Tangible Assets | -329.11% | -630.01% | -650.50% | -208.27% | -105.12% |
| Earnings Yield | -20.66% | -16.56% | -22.96% | -14.11% | -8.08% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1147.22 | 1951.87 | 0.00 | 543.07 | 670.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -0.32 | -0.19 | 0.00 | -0.67 | -0.54 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.32 | 0.19 | 0.00 | 0.67 | 0.54 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.90 | -0.47 | -1.00 | -1.10 | -1.07 |
| Free Cash Flow Per Share | -0.90 | -0.47 | -1.00 | -1.12 | -1.13 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -964.57 | -406.32 | -65.06 | -17.12 |
| Capital Expenditure Coverage Ratio | 0.00 | -964.57 | -406.32 | -65.06 | -17.12 |
| Operating Cash Flow Coverage Ratio | -0.61 | -1.85 | -6.18 | -8.61 | -7.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -4.51% | -5.30% | -16.86% | -11.33% | -4.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.84 | -6.05 | -4.36 | -7.09 | -12.38 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -19.75 | -4.63 | -4.04 | -21.26 | 23.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -22.15 | -18.87 | -5.93 | -8.83 | -20.70 |
| Price-to-Operating Cash Flow Ratio | -22.15 | -18.89 | -5.95 | -8.96 | -21.91 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | -0.00 | 0.04 | 0.27 | -0.06 |
| Enterprise Value Multiple | -11.23 | -11.35 | -4.83 | 381.63 | -12.40 |
| Enterprise Value | 382.35M | 129.97K | 82.73K | -6.66M | 244.05K |
| EV to EBITDA | -11.23 | -11.35 | -4.83 | 381.63 | -12.40 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -23.79 | -19.23 | -5.97 | 432.46 | -19.50 |
| EV to Operating Cash Flow | -23.79 | -19.25 | -5.99 | 439.10 | -20.63 |
| Tangible Book Value Per Share | -0.46 | -2.03 | -1.57 | -0.56 | 0.89 |
| Shareholders’ Equity Per Share | -1.00 | -1.93 | -1.47 | -0.46 | 1.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.10 | -1.48 | -1.36 | -1.39 | -1.89 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 |
| Interest Burden | 2.12 | 1.82 | 1.08 | 1081.57 | 1053.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.22 | 0.32 | 0.73 | 0.79 | 0.56 |
Currency in ILS
